fbpx

Extra treatment option for critically ill patients

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Critically ill patients now have an extra treatment option, thanks to doctors at Wesley Medical Research.

Sepsis kills more Australians than breast cancer, colon cancer or traffic accidents. A new drug has just been successfully trialled in patients admitted to intensive care units with extremely low blood pressure. The target patients were those whose blood pressure had not responded to standard treatments, even in extreme doses. Low blood pressure is potentially very dangerous and can result in death.

“Wesley Medical Research supported The Wesley Hospital as the highest recruiting site out of eight in Queensland for this major trial. This shows that here at the Wesley we are part of significant research giving critically ill patients new treatment options,” said Prof David Paterson, CEO of Wesley Medical Research.

 

Read the full press release here

 

More to explore...

[Video] Panel Pledge Live

On June 18th 2020, Wesley Medical Research and its world-renowned local research leadership team pledged its support to the global medical community, to fast track answers to combat COVID-19, at the official opening of the COVID-19 Rapid Response Research Centre.

Read More »

COVID-19 Rapid Response Research Centre Launch and Researcher Panel Pledge Live

This event will feature a live panel discussion facilitated by Professor Ian Frazer, leading researcher and immunologist, in conversation with our world-renowned local research leadership team. At this event, you will hear the latest findings and insights into our key research methodologies that provide a holistic framework to benefit those on the frontline; those who are critically ill; those with pre-existing conditions and those vulnerable to mental health concerns.

Read More »

Wesley Medical Research

Scroll to Top